12:00 AM
 | 
Jun 08, 2009
 |  BioCentury  |  Finance

Clinical rationing

Clinical rationing

Biotechs with compounds in the clinic and beyond continue to get the lion's share of funding in Europe, but the amount has fallen along with overall funding for the industry. For 2008 through 1Q09, European biotechs in the clinic raised $1.1 billion, or 45% of the total $2.5 billion...

Read the full 227 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >